Antiviral pills for #COVID19 may be available soon: 3 in clinical trials, results expected as soon as late fall/winter: Merck & Ridgeback Biotherapeutics’ #molnupiravir ; Pfizer’s #PF07321332, & Roche & Atea’s #AT527 usatoday.com/story/news/hea…
“only one antiviral drug, remdesivir, has been approved to treat #COVID. But it is given intravenously to patients ill enough to be hospitalized, & is not intended for early, widespread use. By contrast, the top contenders under study can be packaged as pills.”
“That would mean millions …could have access to a daily orally administered medication, ideally a single pill, that could be taken for five to 10 days at the first confirmation of #COVID19 infection”
Ok—not to be a party pooper here, but does it matter very much if it affects viral loads when you take it “at first signs of #COVID19” because by time you’re symptomatic—you’re passing out of phase of peak viral shedding..?
I guess if someone was tested before symptomatic or asymptomatic that reduction of viral load by taking anti-viral pill for #COVID19 would be more impactful?
“Like the monoclonal antibodies, antiviral pills would be no substitute for vaccination, said Griffin. They would be another tool to fight COVID. “It’s nice to have another option,” he said.” #COVID19 #antiviral
• • •
Missing some Tweet in this thread? You can try to
force a refresh
